Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Peptide P-selectin inhibitors described by Centocor

May 20, 1997

BMS describes angiotensin II antagonists

May 20, 1997

Ribi ImmunoChem offers licenses for cardioprotectant

May 19, 1997

Antiproliferative effects of PCA-4230 in vascular smooth muscle cells

May 16, 1997

SmithKline Beechan to market Kissei's tranilast

May 15, 1997

Antiischemic potassium channel activators described by BMS

May 15, 1997

Selective alpha1b-adrenoceptor blockers from Merck & Co.

May 14, 1997

ET antagonists described by Ciba-Geigy Japan (Novartis)

May 12, 1997

FDA approves Mylan's generic extended-release diltiazem

May 9, 1997

Mibefradil evaluated for impact on mortality in large CHF trial

May 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...